Improving Patient Experience and Outcomes Through Evidence-Based Regenerative Medicine

RegenMed Newsletter

  • Mission

    “Regenerative medicine” is about how cells, factors, proteins, tissues and other basic elements of the body work together to promote health, function and longevity. Regen Med is about how hospitals, scientists, individual clinicians, medical societies, payors and regulators collaborate to exploit for the benefit of patients — in an evidence-based manner — this broad, exciting field.

    At the core of Regen Med’s mission are two, mutually-supporting pillars: inCytes™ and Human/Cell Tissue Centers. These provide the foundation for cost-efficient delivery of evidence-based, regulatorily compliant regenerative medicine procedures (whether primary or adjunct). That same foundation also supports studies, trials, product incubation, value-based medicine, improved patient experience, professional education and clinical growth. Finally, this foundation enables deep, ongoing and professionally-rewarding collaboration among Regen Med Network members around the world.”

Suggested Literature

Balancing Safety and Innovation for Cell-Based ...


Building RE.GA.IN Case Study


inCytes Overview

Alan J. Russell, Ph.D Alan J. Russell, Ph.D Board Member
Michael O’Regan, Ph.D Michael O’Regan, Ph.D Market Development Europe
Highmark Distinguished Career Professor, Carnegie Mellon University Chief Innovation Officer, Allegheny Health Network Dr. Alan Russell (Ph.D. in Biological Chemistry, 1987, Imperial College of Science and Technology, University of London) is the Highmark Distinguished Career Professor at Carnegie Mellon University and Director of CMU’s Disruptive Health Technology Institute. Dr. Russell holds appointments in the Institute… Full bio
Following completion of his PhD in Molecular Biology at the National University of Ireland, Michael entered industry and took up a position as a Research Scientist, and subsequently Project Leader, at French Biotechnology company, Transgene where he led applied research projects in biotechnology/molecular biology in the framework of contracts with multinational companies. He then joined… Full bio
J. Peter Rubin, M.D. J. Peter Rubin, M.D. Board Member
Peter Johnson, M.D. Peter Johnson, M.D. Board Member
J. Peter Rubin, MD, is Chair of the Department of Plastic Surgery and the UPMC Endowed Professor of Plastic Surgery, as well as Professor of Bioengineering. He earned his undergraduate degree in biology from Grinnell College and his M.D. degree from Tufts University School of Medicine.  He completed a categorical residency training program in general… Full bio
Peter C. Johnson, MD is a University of Notre Dame and SUNY Upstate Medical University graduate. After General and Plastic Surgery training, Dr. Johnson practiced reconstructive surgery for ten years at U. Pittsburgh where he founded and was the first President of the Pittsburgh Tissue Engineering Initiative.  Subsequent roles were co-founder/CEO of Tissue Informatics, EVP… Full bio
Diego Correa, M.D., M.Sc., Ph.D. Diego Correa, M.D., M.Sc., Ph.D. Board Member
Christian Jorgensen, M.D., Ph.D. Christian Jorgensen, M.D., Ph.D. Board Member
Diego Correa has over 15 years of basic and translational research experience in the areas of Adult Stem Cell Biology and Regenerative Medicine, emphasizing on musculoskeletal tissue development, injury and repair, tissue engineering, stem cell-based therapies and oncology (adult stem cells in primary and metastatic tumor formation). Dr Correa has been the recipient of various… Full bio
Christian Jorgensen's clinical interests are in stem cells, immunology and rheumatology. He is head of the clinical unit, "Immuno-therapy Rheumatology”, at the University Hospital “Lapeyronie” (Montpellier). He leads Institute IRMB dedicated to regenerative medicine, and the clinical department for immunotherapy with 20 beds dedicated to biotherapy applied to Rheumatoid Arthritis and other autoimmune diseases. Pr… Full bio
J. William Futrell, M.D. J. William Futrell, M.D. Not specified
Dietrich Stephan, Ph.D. Dietrich Stephan, Ph.D. Board Member
Former Professor and Chief of Plastic Surgery at the University of Pittsburgh Medical Center for 21 years. Dr. Futrell served as a President of the American Association of Plastic Surgeons and multiple other medical organizations and author or co-author of more than 200 peer-reviewed scientific publications. As an entrepreneur he is co-inventor of multiple patents… Full bio
Dietrich A. Stephan, Ph.D. is currently the Chairman of the Department of Human Genetics at the University of Pittsburgh, and leads the effort in Public Health Genetics and Translational Acceleration at the Personalized Medicine Institute of the University of Pittsburgh/UPMC. Stephan most recently founded and served as President and CEO of Silicon Valley Biosystems, a… Full bio
Claude T. Moorman, M.D. Claude T. Moorman, M.D. Board Member
James R. Urbaniak, M.D. James R. Urbaniak, M.D. Board Member
Professor and Vice Chair of Orthopaedic Surgery at Duke, Director of the Duke Sports Medicine Center, Head Team Physician for Duke University, Professor Evolutionary Anthropology. Dr. Moorman played football at Duke University and received his medical degree in 1987 from the University of Cincinnati College of Medicine. Dr. Moorman completed an orthopaedic residency at Duke… Full bio
Dr. Urbaniak is recognized as a pioneer in the replantation of severed digits and hands. For the past 40 years he has conducted significant research in the area of microsurgical reconstruction of traumatized extremities and avascular necrosis of the femoral head. This research has been supported for over 20 years by a R01 grant from… Full bio